Literature DB >> 9083332

Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features.

T Hirano1, K Fujioka, B Franzèn, K Okuzawa, K Uryu, H Shibanuma, K Numata, C Konaka, Y Ebihara, M Takahashi, H Kato, G Auer.   

Abstract

TA01 (molecular weight 35.0 kDa, isoelectric point 5.45) and TA02 (molecular weight 35.0 kDa, isoelectric point 5.29) polypeptides were detected using two-dimensional polyacrylamide gel electrophoresis (2-DE). A previous study has shown that these polypeptides are distributed in primary adenocarcinomas and some large-cell carcinomas of the lung. However, various expression levels of TA01 and TA02 polypeptides were demonstrated in adenocarcinoma, while large-cell carcinoma expressed low levels. To evaluate the relationship between the expression of TA01 and TA02 polypeptides and the histocytological features of primary adenocarcinoma of the lung, these two polypeptides were analysed by 2-DE combined with a non-enzymatic sample preparation technique, and their expression levels were compared with the histocytological features of primary lung adenocarcinoma. Out of 57 primary lung adenocarcinoma cases, 46 cases (80.7%) and 52 cases (91.2%) expressed TA01 and TA02 polypeptides respectively. Furthermore, the expression levels of TA01 and TA02 polypeptides correlated with the degree of cellular atypia, structural atypia and histocytological differentiation of primary lung adenocarcinoma. On the other hand, these two polypeptides were not detected in adenocarcinoma of the lung, metastatic from the colon and mammary glands. High expression of TA01 and TA02 polypeptides reflected the differentiation of primary adenocarcinoma in the lung. These two polypeptides are valuable in determining the histocytological differentiation of primary lung adenocarcinoma as well as in distinguishing between primary and metastatic adenocarcinoma of the lung.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083332      PMCID: PMC2222755          DOI: 10.1038/bjc.1997.169

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  [Diagnostic value of the assay of carbohydrate antigen 19-9 in patients with primary bronchial cancer].

Authors:  G Letanche; I Ogier; P Weynants; D J Hartmann; G Ville; J F Cordier; J Brune
Journal:  Rev Pneumol Clin       Date:  1985

Review 2.  The pathology of lung cancer--changing concepts and newer diagnostic techniques.

Authors:  A F Gazdar; R I Linnoila
Journal:  Semin Oncol       Date:  1988-06       Impact factor: 4.929

3.  Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer.

Authors:  G Buccheri; D Ferrigno
Journal:  Chest       Date:  1988-03       Impact factor: 9.410

4.  Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity.

Authors:  J H Morrissey
Journal:  Anal Biochem       Date:  1981-11-01       Impact factor: 3.365

5.  Subtypes of small cell carcinoma of the lung: morphometric, ultrastructural, and immunohistochemical analyses.

Authors:  H Nomori; Y Shimosato; T Kodama; S Morinaga; T Nakajima; S Watanabe
Journal:  Hum Pathol       Date:  1986-06       Impact factor: 3.466

6.  The value of carcinoembryonic antigen in patients with carcinoma of the lung.

Authors:  R G Vincent; T M Chu; W W Lane
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

7.  Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.

Authors:  D N Carney; P J Marangos; D C Ihde; P A Bunn; M H Cohen; J D Minna; A F Gazdar
Journal:  Lancet       Date:  1982-03-13       Impact factor: 79.321

8.  The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes.

Authors:  P A Radice; M J Matthews; D C Ihde; A F Gazdar; D N Carney; P A Bunn; M H Cohen; B E Fossieck; R W Makuch; J D Minna
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860

9.  Identification, cellular localization, isolation, and characterization of human Clara cell-specific 10 KD protein.

Authors:  G Singh; J Singh; S L Katyal; W E Brown; J A Kramps; I L Paradis; J H Dauber; T A Macpherson; N Squeglia
Journal:  J Histochem Cytochem       Date:  1988-01       Impact factor: 2.479

10.  Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures.

Authors:  A F Gazdar; M H Zweig; D N Carney; A C Van Steirteghen; S B Baylin; J D Minna
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

View more
  7 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

2.  Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.

Authors:  Qing Kay Li; Punit Shah; Yan Li; Paul O Aiyetan; Jing Chen; Rex Yung; Daniela Molena; Edward Gabrielson; Frederic Askin; Daniel W Chan; Hui Zhang
Journal:  J Proteome Res       Date:  2013-07-11       Impact factor: 4.466

3.  Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.

Authors:  Peng Zhang; Yi-Ping Han; Ling Huang; Qiang Li; DA-Lie Ma
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

4.  Proteomic comparison of two-dimensional gel electrophoresis profiles from human lung squamous carcinoma and normal bronchial epithelial tissues.

Authors:  Cui Li; Xianquan Zhan; Maoyu Li; Xiaoying Wu; Feng Li; Jianling Li; Zhiqiang Xiao; Zhuchu Chen; Xueping Feng; Ping Chen; Jingyun Xie; Songping Liang
Journal:  Genomics Proteomics Bioinformatics       Date:  2003-02       Impact factor: 7.691

5.  Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A.

Authors:  T Hirano; G Auer; M Maeda; Y Hagiwara; S Okada; T Ohira; K Okuzawa; K Fujioka; B Franzén; N Hibi; T Seito; Y Ebihara; H Kato
Journal:  Jpn J Cancer Res       Date:  2000-10

6.  Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.

Authors:  T Ueno; S Linder; G Elmberger
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

7.  Differential tissue-specific protein markers of vaginal carcinoma.

Authors:  K Hellman; A A Alaiya; S Becker; M Lomnytska; K Schedvins; W Steinberg; A-C Hellström; S Andersson; U Hellman; G Auer
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.